Explore the latest in urology, including recent advances in treatment of UTIs, incontinence, and prostate and bladder cancers.
This cohort study examines health-related quality of life in men with prostate cancer who have undergone prostatectomy only vs prostatectomy with radiotherapy within or beyond 1 year following surgery.
This cohort study uses data from the Children With Vesicoureteral Reflux trial to assess estimated glomerular filtration rate (eGFR) changes in participants with vs without recurrent urinary tract infections.
This decision analytic modeling study estimates the long-term outcomes of prostate-specific membrane antigen positron emission tomography (PSMA-PET) for staging recurrent prostate cancer.
This randomized clinical trial compares 24-hour vs extended perioperative antibiotic prophylaxis to prevent surgical site infection in patients undergoing cystectomy with urinary diversion.
This cross-sectional study examines whether transfers and travel distance have changed for children with 4 time-sensitive surgical conditions from 2002 to 2017 and whether these changes have differed by rural vs urban status.
This cohort study examines whether there is an association of diet quality and dietary inflammatory potential with prostate cancer grade reclassification in men with grade group 1 disease undergoing active surveillance.
This secondary analysis of a randomized clinical trial examines the association of prior prostate-directed local therapy and first-line apalutamide with survival among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC).
This prognostic study examines the prognostic value of circulating tumor cell count in patients with metastatic hormone-sensitive prostate cancer (mHSPC).
This cohort study evaluates the prevalence of prostate cancer among transgender women in the US and examines factors associated with prostate cancer, biochemical recurrence, and bone metastases in transgender patients.
This randomized clinical trial investigates if intraoperative prophylactic tranexamic acid reduces blood transfusion in patients undergoing open radical cystectomy for bladder cancer.
This Viewpoint explores how guideline groups can come together to agree on a framework that produces clear and unified recommendations.
This cross-sectional study uses US National Health and Nutrition Examination Survey data to examine temporal and sociodemographic trends in urinary concentrations of organophosphate flame-retardant metabolites among children, youths, and adults from 2011 to 2020.
This cohort study examines the incidence, prevalence, and survival rates of prostate cancer in the UK from 2000 to 2021.
This randomized clinical trial compares the effect of transperineal vs transrectal prostate biopsy on infection rates after biopsy.
This nonrandomized clinical trial evaluates the safety, pharmacokinetics, and preliminary efficacy of rogaratinib in combination with the programmed cell death 1 ligand 1 inhibitor atezolizumab in cisplatin-ineligible patients with FGFR messenger RNA–positive, locally advanced/metastatic urothelial cancer.
This comparative effectiveness research investigates factors associated with the difference in the observed effect of lutetium Lu 177 vipivotide tetraxetan prostate-specific membrane antigen on overall survival between the TheraP and VISION randomized clinical trials among patients with metastatic castration-resistant prostate cancer.
Customize your JAMA Network experience by selecting one or more topics from the list below.